B-cell maturation antigen (BCMA) in multiple myeloma: the new frontier of targeted therapies

Sanchez, L; Dardac, A; Madduri, D; Richard, S; Richter, J

Richter, J (corresponding author), Icahn Sch Med Mt Sinai, Multiple Myeloma Program, Tisch Canc Inst, 1 Gustave L Levy Pl, New York, NY 10029 USA.

THERAPEUTIC ADVANCES IN HEMATOLOGY, 2021; 12 ():

Abstract

Outcomes of patients with multiple myeloma (MM) who become refractory to standard therapies are particularly poor and novel agents are greatly needed ......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索